• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Proceedings of the 2015 AASOG conference: Reducing disparities in sarcoidosis through personalized care and increased detection.

作者信息

Nabeel Hamzeh, Marc A Judson, Lisa A Maier

机构信息

Division of Environmental and Occupational Health Sciences, National Jewish Health, Denver, Colorado, Department of Medicine, National Jewish Health, Denver, CO, USA.

Albany Medical College, Division of Pulmonary & Critical Care Medicine, Albany, NY, U.S.A.

出版信息

Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(3):264-268. doi: 10.36141/svdld.v34i3.5666. Epub 2020 Mar 9.

DOI:10.36141/svdld.v34i3.5666
PMID:32476856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7170104/
Abstract

The 2015 annual meeting of the Americas Association of Sarcoidosis and Other Granulomatous Disorders (AASOG) was held on September 25 and 26 at the University of Colorado Anschutz Medical Campus in Aurora, CO, U.S.A. The meeting was hosted by National Jewish Health and the theme of the meeting was "Reducing Disparities in Sarcoidosis through Personalized Care and Increased Detection". The meeting was endorsed by the American Thoracic Society (ATS) and the Foundation for Sarcoidosis Research (FSR), and was conducted through support provided by the National Institutes of Health (NIH), particularly the National Heart Lung and Blood Institute (NHLBI), and an unrestricted educational grant from Mallinckrodt, Inc. The meeting participants were predominantly from North America, and included preeminent experts and emerging clinical scientists engaged in sarcoidosis research. The AASOG meeting was held in parallel with a sarcoidosis patient conference that was organized and funded by the Foundation of Sarcoidosis Research (FSR). The AASOG talks covered various state-of-the-arts topics related to sarcoidosis research and care; most notable were talks focusing on preliminary and emerging data from the Genomic Research in Alpha-1 antitrypsin Deficiency and Sarcoidosis (GRADS) study, recent novel immunological and genomic discoveries that further our understanding of sarcoidosis disease pathogenesis, results from clinical trials in sarcoidosis and proposals of novel therapeutic targets for the treatment of sarcoidosis, the introduction of the FSR sponsored clinical studies network, insights from other granulomatous diseases, and a focus on extra-pulmonary sarcoidosis, particularly cardiac disease, small fiber neuropathy, and fatigue. A session dedicated to scientific abstracts from predominantly junior investigators and five oral abstract presentations brought the conference to a conclusion. A brief overview and selected excerpts of the 2015 AASOG meeting proceedings are provided herein. .

摘要

相似文献

1
Proceedings of the 2015 AASOG conference: Reducing disparities in sarcoidosis through personalized care and increased detection.
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(3):264-268. doi: 10.36141/svdld.v34i3.5666. Epub 2020 Mar 9.
2
Proceedings of the Americas Association of Sarcoidosis and Other Granulomatous Diseases (AASOG) 2017 annual meeting.美洲结节病及其他肉芽肿性疾病协会(AASOG)2017年年会会议记录
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(1):91-94. doi: 10.36141/svdld.v35i1.7325. Epub 2018 Apr 28.
3
New advances in the development of sarcoidosis models: a synopsis of a symposium sponsored by the Foundation for Sarcoidosis Research.结节病模型开发的新进展:结节病研究基金会主办的研讨会纪要
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(1):2-4. doi: 10.36141/svdld.v35i1.7032. Epub 2018 Apr 28.
4
Proceedings of the 2014 AASOG conference.
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):359-63.
5
Something going on in Milan: a review of the 4th International PhD Student Cancer Conference.米兰正在发生的一些事:第四届国际博士生癌症会议综述
Ecancermedicalscience. 2010;4:198. doi: 10.3332/ecancer.2010.198. Epub 2010 Nov 10.
6
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
7
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis Protocol.α-1抗胰蛋白酶缺乏症与结节病基因组研究(GRADS)的原理与设计。结节病研究方案。
Ann Am Thorac Soc. 2015 Oct;12(10):1561-71. doi: 10.1513/AnnalsATS.201503-172OT.
8
The 2nd United Kingdom Extracellular Vesicle Forum Meeting Abstracts: 15 December 2015, Hadyn Ellis Building, Cardiff University.第二届英国细胞外囊泡论坛会议摘要:2015 年 12 月 15 日,卡迪夫大学海登·埃利斯大楼。
J Extracell Vesicles. 2016 Feb 23;5:30924. doi: 10.3402/jev.v5.30924. eCollection 2016.
9
From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.克罗地亚皮肤性病学会史——克罗地亚医学协会及《克罗地亚皮肤性病学学报》重要信息概述
Acta Dermatovenerol Croat. 2018 Dec;26(4):344-348.
10
Occupational and environmental exposures in the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study.在α-1 抗胰蛋白酶缺乏症和结节病的基因组研究(GRADS)中职业和环境暴露。
Respir Med. 2022 Aug-Sep;200:106923. doi: 10.1016/j.rmed.2022.106923. Epub 2022 Jun 30.

本文引用的文献

1
IFN-γ-Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 Cells.产生干扰素-γ的辅助性T细胞17.1在结节病中增多,且比1型辅助性T细胞更普遍。
Am J Respir Crit Care Med. 2016 Jun 1;193(11):1281-91. doi: 10.1164/rccm.201507-1499OC.
2
Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes.结节病血液转录组特征与疾病转归的纵向分析。
Eur Respir J. 2014 Oct;44(4):985-93. doi: 10.1183/09031936.00039714. Epub 2014 Aug 19.
3
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.程序性死亡-1通路的阻断可恢复结节病CD4(+) T细胞的增殖能力。
Am J Respir Crit Care Med. 2014 Sep 1;190(5):560-71. doi: 10.1164/rccm.201401-0188OC.
4
Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis.CD4+ 亚群功能全球逆转与肺结节病自发临床缓解相关。
J Immunol. 2013 Jun 1;190(11):5446-53. doi: 10.4049/jimmunol.1202891. Epub 2013 Apr 29.
5
Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.血清淀粉样蛋白 A 通过 Toll 样受体 2 调节结节病中的肉芽肿性炎症。
Am J Respir Crit Care Med. 2010 Feb 15;181(4):360-73. doi: 10.1164/rccm.200905-0696OC. Epub 2009 Nov 12.
6
FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions.FoxP3+调节性T细胞抑制肉芽肿形成的早期阶段,但对结节病病变影响不大。
Am J Pathol. 2009 Feb;174(2):497-508. doi: 10.2353/ajpath.2009.080580. Epub 2009 Jan 15.
7
The immune paradox of sarcoidosis and regulatory T cells.结节病的免疫悖论与调节性T细胞
J Exp Med. 2006 Feb 20;203(2):359-70. doi: 10.1084/jem.20050648. Epub 2006 Jan 23.
8
HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.人类白细胞抗原-DRB1*1101:黑人和白人结节病的一个重要风险因素。
Am J Hum Genet. 2003 Oct;73(4):720-35. doi: 10.1086/378097. Epub 2003 Aug 20.
9
Sarcoidosis severity and socioeconomic status.结节病的严重程度与社会经济地位
Eur Respir J. 2001 Sep;18(3):499-506. doi: 10.1183/09031936.01.00056201.
10
Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.结节病声明。美国胸科学会(ATS)、欧洲呼吸学会(ERS)和结节病及其他肉芽肿性疾病世界协会(WASOG)的联合声明,1999年2月经ATS董事会和ERS执行委员会通过。
Am J Respir Crit Care Med. 1999 Aug;160(2):736-55. doi: 10.1164/ajrccm.160.2.ats4-99.